We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+17.52%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$11.2B
AUM Growth
+$880M
Cap. Flow
-$473M
Cap. Flow %
-4.22%
Top 10 Hldgs %
52.23%
Holding
59
New
9
Increased
20
Reduced
12
Closed
14

Top Buys

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$525M
2
HUM icon
Humana
HUM
+$325M
3
CI icon
Cigna
CI
+$303M
4
LYB icon
LyondellBasell Industries
LYB
+$286M
5
NXPI icon
NXP Semiconductors
NXPI
+$188M

Top Sells

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$794M
2
CVS icon
CVS Health
CVS
+$556M
3
DD icon
DuPont de Nemours
DD
+$461M
4
FDC
First Data Corporation
FDC
+$267M
5
EBAY icon
eBay
EBAY
+$202M

Sector Composition

Rank Sector Weight
1 Healthcare 52.71%
2 Technology 13.52%
3 Materials 12.73%
4 Communication Services 9.13%
5 Industrials 6.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
51
CVS Health
CVS
$133B
– –
-8,489,991
Closed -$556M
DD icon
52
CALL
DuPont de Nemours
DD
$19.3B
– –
-118,464
Closed -$16M
DD icon
53
DuPont de Nemours
DD
$19.3B
– –
-3,402,090
Closed -$461M
EBAY icon
54
eBay
EBAY
$48.7B
– –
-7,192,991
Closed -$202M
FDX icon
55
FedEx
FDX
$74.1B
– –
-360,551
Closed -$58.2M
WBA
56
DELISTED
Walgreens Boots Alliance
WBA
– –
-961,747
Closed -$65.7M
VER
57
DELISTED
VEREIT, Inc.
VER
– –
-925,014
Closed -$33.1M
AGN
58
DELISTED
Allergan plc
AGN
– –
-200,971
Closed -$26.9M
SHPG
59
DELISTED
Shire pic
SHPG
– –
-4,563,127
Closed -$794M
1 2
3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Glenview Capital Management held 59 positions worth $11.2B, up 8.5% from $10.3B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Glenview Capital Management withdrew a net $473M in Q1 2019, closing 14 positions and reducing 12 holdings. Its most notable exit was Shire pic, an estimated $794M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 53% a quarter earlier, followed by Technology and Materials.

Against the trend, Glenview Capital Management opened a new position in Takeda Pharmaceutical worth $532M.

  • Glenview Capital Management's largest Q1 2019 buy was Takeda Pharmaceutical: 26,112,660 shares worth $532M.
  • Glenview Capital Management added most to Humana in Q1 2019, an estimated $325M increase.
  • Glenview Capital Management's biggest Q1 2019 reduction was First Data Corporation, cutting an estimated $267M.
  • Glenview Capital Management fully exited Shire pic in Q1 2019, selling an estimated $794M.
  • Glenview Capital Management's ten largest holdings make up 52% of its $11.2B portfolio in Q1 2019.
  • Glenview Capital Management opened 9 new positions and closed 14 in Q1 2019.
  • Glenview Capital Management's portfolio value rose 8.5% quarter-over-quarter to $11.2B.

Based on Glenview Capital Management's 13F filing for Q1 2019, filed 15 May 2019.